Maeda T, Kurahashi K, Matsunaga M, Inoue K, Inoue M
Department of Neurology, Aomori Prefectural Central Hospital, Japan.
No To Shinkei. 1997 Sep;49(9):847-51.
In a familial amyotrophic lateral sclerosis (FALS) with SOD-1 mutation (Asn 86-Ser), there were intra-familial clinical diversities. The proband, a daughter patient, shows a mild clinical course of 16 years. Her father died of respiratory failure in 3 years. His initial symptom was weakness of upper extremity. The daughter's first symptom was that of lower extremities. Her respiratory-assist started after 9 years from the onset. She is alive under whole-day respiratory assist while she had been taking nutrients per os for 15 years. Her abilities of swallowing remain, even more dependent of tube-feeding (15 years after the onset). The fact of the presence of intra-familial clinical varieties with SOD-1 mutation in FALS suggests that the mutation is not an exclusive factor to determine the clinical phenotype, age of the onset and rapidity of illness of FALS associated with SOD-1 mutation. We collect reports of FALS with SOD-1 mutation which have similar diversities of intra-familial clinical manifestations as our family. Varieties of intra-familial clinical manifestations of motor neuron disease are shown in 9 families with SOD-1 mutation. The genetic error appears to have a limit, and is not a exclusive cause of FALS. However, we should not underestimate the significance of the discovery of a gene, since it might offer a clue to still unanswered riddle of ALS pathogenesis.
在一个伴有超氧化物歧化酶-1(SOD-1)突变(天冬酰胺86-丝氨酸)的家族性肌萎缩侧索硬化症(FALS)病例中,存在家族内临床差异。先证者为一名女性患者,临床病程长达16年,症状较轻。她的父亲在3年后死于呼吸衰竭,其最初症状是上肢无力。而女儿的首发症状是下肢症状。她在发病9年后开始接受呼吸辅助治疗。在依靠全时呼吸辅助的情况下,她存活了下来,并且已经经口摄入营养物质15年。即便在发病15年后更加依赖鼻饲,她仍保留吞咽能力。FALS中存在伴有SOD-1突变的家族内临床差异这一事实表明,该突变并非决定与SOD-1突变相关的FALS临床表型、发病年龄和疾病进展速度的唯一因素。我们收集了与我们家族具有相似家族内临床表现差异的伴有SOD-1突变的FALS病例报告。在9个伴有SOD-1突变的家族中展示了运动神经元病家族内临床表现的多样性。遗传缺陷似乎存在一定局限性,并非FALS的唯一病因。然而,我们不应低估发现一个基因的重要性,因为它可能为肌萎缩侧索硬化症发病机制中仍未解开的谜团提供线索。